- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Profitable Climbers
Australian Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Telix Pharmaceuticals
Market Cap: AU$5.7b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$16.89
7D
-16.6%
1Y
-6.1%
EZZ Life Science Holdings
Market Cap: AU$100.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.12
7D
3.4%
1Y
11.3%